Merck (MRK) Stock News, Forecasts & Analyst Outlook — What Investors Are Watching on December 12, 2025
Merck & Co., Inc. (NYSE: MRK) heads into mid‑December with its stock back near the psychologically important $100 level—and with the kind of headline mix that makes long-term pharma investing feel like chess played on a trampoline: upbeat analyst upgrades
